C4 Therapeutics Inc

CCCC

Company Profile

  • Business description

    C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

  • Contact

    490 Arsenal Way
    Suite 120
    WatertownMA02472
    USA

    T: +1 617 231-0700

    https://www.c4therapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    110

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,743.5014.40-0.16%
CAC 407,656.1227.61-0.36%
DAX 4023,317.81116.84-0.50%
Dow JONES (US)42,171.6644.14-0.10%
FTSE 1008,843.479.440.11%
HKSE23,710.69269.61-1.12%
NASDAQ19,546.2725.180.13%
Nikkei 22538,623.19261.96-0.67%
NZX 50 Index12,601.5225.80-0.20%
S&P 5005,980.871.85-0.03%
S&P/ASX 2008,518.9012.30-0.14%
SSE Composite Index3,388.811.400.04%

Market Movers